| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 27, 2008
From the Hypertension and Vascular Research Division (T.-D.L., X.-P.Y., Y.-H.L., E.G.S., M.A.C., P.J.P., O.A.C.), Department of Internal Medicine, Henry Ford Hospital, Detroit, Mich; and PDL BioPharma, Inc (W.A.K.), Fremont, Calif. * To whom correspondence should be addressed. E-mail: ocarret1{at}hfhs.org.
Abstract—Angiotensin II (Ang II)–induced hypertension is associated with an inflammatory response that may contribute to the development of target organ damage. We tested the hypothesis that, in Ang II–induced hypertension, CC chemokine receptor 2 (CCR2) activation plays an important role in the development of renal fibrosis, damage, and dysfunction by causing oxidative stress, macrophage infiltration, and cell proliferation. To test this hypothesis, we used CCR2 knockout mice (CCR2-/-). The natural ligand of CCR2 is monocyte chemoattractant protein-1, a chemokine important for macrophage recruitment and activation. CCR2-/- and age-matched wild-type (CCR2+/+) C57BL/6J mice were infused continuously with either Ang II (5.2 ng/10 g per minute) or vehicle via osmotic minipumps for 2 or 4 weeks. Ang II infusion caused similar increases in systolic blood pressure and left ventricular hypertrophy in both strains of mice. However, in CCR2-/- mice with Ang II–induced hypertension, oxidative stress, macrophage infiltration, albuminuria, and renal damage were significantly decreased, and glomerular filtration rate was significantly higher than in CCR2+/+ mice. We concluded that, in Ang II–induced hypertension, CCR2 activation plays an important role in the development of hypertensive nephropathy via increased oxidative stress and inflammation.
Revised on March 24, 2008
Role of Inflammation in the Development of Renal Damage and Dysfunction in Angiotensin II–Induced Hypertension
Tang-Dong Liao;
Related Article:
Hypertension 2008 52: 205-206.
This article has been cited by other articles:
![]() |
Y. Wang and Z. Sun Klotho Gene Delivery Prevents the Progression of Spontaneous Hypertension and Renal Damage Hypertension, October 1, 2009; 54(4): 810 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sharkey, H. P. Fainberg, V. Wilson, E. Harvey, D. S. Gardner, M. E. Symonds, and H. Budge Impact of Early Onset Obesity and Hypertension on the Unfolded Protein Response in Renal Tissues of Juvenile Sheep Hypertension, June 1, 2009; 53(6): 925 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ryan Young Investigator Award Lecture of the APS Water and Electrolyte Homeostasis Section, 2008: The pathophysiology of hypertension in systemic lupus erythematosus Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1258 - R1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rodriguez-Iturbe, N. D. Vaziri, and R. J. Johnson Inflammation, Angiotensin II, and Hypertension Hypertension, November 1, 2008; 52(5): e135 - e135. [Full Text] [PDF] |
||||
![]() |
T.-D. Liao, X.-P. Yang, Y.-H. Liu, E. G. Shesely, M. A. Cavasin, W. A. Kuziel, P. J. Pagano, and O. A. Carretero Response to Inflammation, Angiotensin II, and Hypertension Hypertension, November 1, 2008; 52(5): e136 - e136. [Full Text] [PDF] |
||||
![]() |
E. L. Schiffrin The Flame That Lights the Fire: Oxidative Stress, Inflammation, and Renal Damage in Angiotensin II-Induced Hypertension Hypertension, August 1, 2008; 52(2): 205 - 206. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |